Healthcare

Healthcare services provider Mednax has captured market attention with a robust quarterly performance and a significant new capital return initiative....

Radiation therapy specialist Accuray Incorporated has reported a mixed financial performance for its most recent fiscal year. The company's service...

Despite posting robust quarterly earnings and announcing a strategically significant partnership, Quest Diagnostics finds itself facing unexpected hesitation from Baird's...

The investment narrative surrounding transplant diagnostics firm CareDx is one of stark contrasts. The company’s latest quarterly results revealed significant...

Aldeyra Therapeutics has announced significant regulatory progress for its two leading pharmaceutical candidates, ADX-2191 and reproxalap. These developments position the...

A medical device manufacturer's extraordinary pivot to cryptocurrency investment has placed the company in a precarious position. Semler Scientific, traditionally...

Jazz Pharmaceuticals has achieved two significant regulatory milestones for its oncology therapeutic, Modeyso. The company obtained both an accelerated approval...

Eli Lilly stands poised to revolutionize obesity treatment with its experimental oral medication Orforglipron, following outstanding Phase 3 clinical trial...

Dental products manufacturer Envista Holdings is capturing significant attention from Wall Street following a robust quarterly earnings report. The company's...

Investors in Rockwell Medical experienced significant volatility as the dialysis product manufacturer's stock declined 5% on Friday. This pullback arrived...